← Dow overview

Dow vs Solstice Advanced Materials: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Dow Inc (DOW)

Q3 2026
▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

  • Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.

    New trade barrier directly affecting Dow's sales and pricing power.

  • Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.

    Portfolio move with major cash and strategic implications for Dow's balance sheet.

  • Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.

    Direct reduction in expected earnings, a key driver of stock value.

  • Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.

    Capital allocation shift affects shareholder returns and financial risk.

August 2026
▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

  • Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.

    New trade barrier directly affecting Dow's sales and pricing power.

  • Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.

    Portfolio move with major cash and strategic implications for Dow's balance sheet.

  • Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.

    Direct reduction in expected earnings, a key driver of stock value.

  • Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.

    Capital allocation shift affects shareholder returns and financial risk.

Latest
▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

  • Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.

    New trade barrier directly affecting Dow's sales and pricing power.

  • Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.

    Portfolio move with major cash and strategic implications for Dow's balance sheet.

  • Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.

    Direct reduction in expected earnings, a key driver of stock value.

  • Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.

    Capital allocation shift affects shareholder returns and financial risk.

Q2 2026
▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

  • RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.

    This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.

  • Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.

    This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.

  • Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.

    This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.

  • Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.

    These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

June 2026
▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

  • RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.

    This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.

  • Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.

    This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.

  • Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.

    This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.

  • Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.

    These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

  • RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.

    This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.

  • Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.

    This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.

  • Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.

    This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.

  • Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.

    These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

Solstice Advanced Materials, Inc (SOLS)

Q3 2026
▲2▼1

Solstice's Element Deal Collapses, Buyback Lifts Shares

  • Element Solutions acquisition announced In June, Solstice agreed to buy Element Solutions for $14.5B in cash and stock. Investors worried about dilution and debt, sending shares down 15%.

    This event triggered the quarter's initial sharp share price drop.

  • Merger terminated, $500M buyback authorized By September, the merger was called off without fees after shareholder pushback. Solstice then announced a $500M buyback, and shares jumped 12.8%.

    This reversal removed the deal overhang and directly boosted the stock.

  • Strong Q2 results and raised guidance Second-quarter sales rose 11% to $1.15B, and management raised its outlook. The company also highlighted its unique US uranium conversion position and growing AI/semiconductor demand.

    These fundamentals supported the stock and provided positive momentum.

  • Analyst views split after deal news UBS stayed bullish, while BMO cut its price target but kept a Buy rating. The mixed views reflected uncertainty around the failed merger and future strategy.

    Analyst reactions influenced investor sentiment during the quarter.

August 2026
▲3

Solstice Goes It Alone: Merger Scrapped, Buyback and Guidance Lift Stock

  • Standalone pure-play after Honeywell breakup Honeywell finished splitting into four companies, leaving Solstice as a standalone specialty materials business focused on refrigerants and nuclear materials. Investors often pay more for a focused company than a conglomerate piece, which can lift the shares over time.

    This is the structural event that created SOLS as an independent stock and frames all later news.

  • Strong Q2 and raised 2026 guidance Solstice's second-quarter sales rose 11% to $1.15 billion, beating its own forecast, and it raised full-year sales and profit guidance. Management said the heaviest plant maintenance is done, which should help margins in the second half.

    Better-than-expected results and higher guidance are a direct, fundamental reason the stock can rise.

  • Merger with Element Solutions terminated; $500M buyback Solstice and Element Solutions called off their $14.5 billion merger with no fees, after shareholder pushback. Solstice then authorized its first $500 million share buyback and kept its 2026 sales guidance, sending the stock up 12.8% as investors welcomed the standalone path.

    This is the period's biggest new event and the main reason SOLS moved sharply higher.

  • Analyst views split after the deal collapse UBS had upgraded Solstice to Buy in July, saying the stock was undervalued and could grow earnings about 18% a year. After the merger ended, BMO cut its price target to $83 from $95 but kept a Buy rating, showing support but also caution about the standalone plan.

    It shows the real counterweight: analysts still see value but have trimmed expectations after the merger fell through.

Latest
▲3

Solstice Goes It Alone: Merger Scrapped, Buyback and Guidance Lift Stock

  • Standalone pure-play after Honeywell breakup Honeywell finished splitting into four companies, leaving Solstice as a standalone specialty materials business focused on refrigerants and nuclear materials. Investors often pay more for a focused company than a conglomerate piece, which can lift the shares over time.

    This is the structural event that created SOLS as an independent stock and frames all later news.

  • Strong Q2 and raised 2026 guidance Solstice's second-quarter sales rose 11% to $1.15 billion, beating its own forecast, and it raised full-year sales and profit guidance. Management said the heaviest plant maintenance is done, which should help margins in the second half.

    Better-than-expected results and higher guidance are a direct, fundamental reason the stock can rise.

  • Merger with Element Solutions terminated; $500M buyback Solstice and Element Solutions called off their $14.5 billion merger with no fees, after shareholder pushback. Solstice then authorized its first $500 million share buyback and kept its 2026 sales guidance, sending the stock up 12.8% as investors welcomed the standalone path.

    This is the period's biggest new event and the main reason SOLS moved sharply higher.

  • Analyst views split after the deal collapse UBS had upgraded Solstice to Buy in July, saying the stock was undervalued and could grow earnings about 18% a year. After the merger ended, BMO cut its price target to $83 from $95 but kept a Buy rating, showing support but also caution about the standalone plan.

    It shows the real counterweight: analysts still see value but have trimmed expectations after the merger fell through.

July 2026
▲3▼1

Solstice's $14.5B Element Deal Shakes Stock, But Growth Story Intact

  • Solstice to acquire Element Solutions for $14.5B, shares drop 15% Solstice announced a $14.5 billion cash-and-stock deal to buy Element Solutions, sending its shares down nearly 15%. The deal dilutes existing shareholders and adds debt, which worries investors. The market's negative reaction shows concern about the price paid and integration risks.

    This is the major new event that directly caused a sharp stock drop and dominates the period.

  • CEO and Cramer defend deal, call pullback a buying opportunity Solstice's CEO said Wall Street misread the deal, blaming hedge funds and arbitrage traders for the sell-off. Jim Cramer called the merger 'very smart' and the pullback a 'terrific buying opportunity.' These endorsements may boost investor confidence and support a price recovery.

    This is new this period and provides a counterweight to the negative market reaction, potentially influencing price direction.

  • Solstice's uranium conversion and AI materials demand drive growth Solstice is the sole US utility-scale provider of uranium conversion services, with strengthening demand prompting capacity expansion. It also supplies specialty materials for AI data centers and semiconductors, benefiting from surging demand. These secular growth drivers underpin the long-term investment case.

    This explains the fundamental demand forces behind Solstice's growth story, which is key to understanding its valuation.

  • Solstice stock up 66% since spinoff, trades at premium valuation Since spinning off from Honeywell nine months ago, Solstice shares have surged about 66%, trading at 30 times forward earnings with expected earnings growth over 20%. The company offers exposure to AI and nuclear energy themes, attracting investor interest despite the recent pullback.

    This provides context on the stock's strong performance and valuation, helping investors assess the current opportunity.

▲3▼1

Solstice's $14.5B Element Deal Shakes Stock, But Growth Story Intact

  • Solstice to acquire Element Solutions for $14.5B, shares drop 15% Solstice announced a $14.5 billion cash-and-stock deal to buy Element Solutions, sending its shares down nearly 15%. The deal dilutes existing shareholders and adds debt, which worries investors. The market's negative reaction shows concern about the price paid and integration risks.

    This is the major new event that directly caused a sharp stock drop and dominates the period.

  • CEO and Cramer defend deal, call pullback a buying opportunity Solstice's CEO said Wall Street misread the deal, blaming hedge funds and arbitrage traders for the sell-off. Jim Cramer called the merger 'very smart' and the pullback a 'terrific buying opportunity.' These endorsements may boost investor confidence and support a price recovery.

    This is new this period and provides a counterweight to the negative market reaction, potentially influencing price direction.

  • Solstice's uranium conversion and AI materials demand drive growth Solstice is the sole US utility-scale provider of uranium conversion services, with strengthening demand prompting capacity expansion. It also supplies specialty materials for AI data centers and semiconductors, benefiting from surging demand. These secular growth drivers underpin the long-term investment case.

    This explains the fundamental demand forces behind Solstice's growth story, which is key to understanding its valuation.

  • Solstice stock up 66% since spinoff, trades at premium valuation Since spinning off from Honeywell nine months ago, Solstice shares have surged about 66%, trading at 30 times forward earnings with expected earnings growth over 20%. The company offers exposure to AI and nuclear energy themes, attracting investor interest despite the recent pullback.

    This provides context on the stock's strong performance and valuation, helping investors assess the current opportunity.

© 2026 MarketIVWhy